Children’s play: Madame Tussauds will be sold to the founding family of Lego for $ 7.6 billionThe museum’s owner is expected to be acquired by a group of investors, including the founding family of Lego, the Blackstone fund and the Canadian pension fund CPPIB
The British Merlin Entertainment, which operates the Madame Tussauds, is expected to buy for $ 7.6 billion, according to overseas reports. Merlin’s share is up 15% after the tender offer.he famous museum’s owner is expected to be acquired by a group of investors, including Kirkby, the investment arm of the founding family of Lego, the Blackstone fund and the Canadian pension fund CPPIB. The deal, which the parties are expected to announce today, includes a 1.2 billion pound debt of the museum’s operatorBuyers will pay 455 pence in cash for each Merlin share. This is a 15% premium on yesterday’s closing price in London. The tender offer reflects Marlin’s value over £ 4.7 billion.The history of the Tussauds Museum began in 1802, the year Madame Tussauds moved her wax collection to London. Every year the museum attracts more than 14 million visitors. At the Tussauds in London there are wax sculptures of celebrities such as David Beckham, Brad Pitt and Kylie Minogue. Tussaud, which operates in Cessington, South England, also operates theme parks such as Elton Towers and the Chesington World of Adventure. Who is the company that invested in the geometries, and what is it trying to achieve?
Sharona Partners is a group of companies owned by the French-Jewish businessman Philippe Bouziz, who is a member of the French-Jewish conglomerate, Which includes a modest investment fund, two operators, a media site and five joint work spaces in Tel Aviv, Kfar Saba and Haifa. However, you probably have not heard of the company, and you are not alone. Many of the entrepreneurs and investors in the large Israeli funds with whom we have spoken have never heard of the group.Since its establishment in 2016 and until today, Sharona Partners has operated relatively quietly. In recent months, the group’s name has begun to rise following a series of new partnerships aimed at rapidly expanding its operations, with the intention of establishing itself as a broad platform that will help Israeli start-ups become international giants.A few months ago, the company announced that it had also added the Israeli technology site Giktim, which expanded its operations to the media field. Giktim was established as an independent blog in 2009, and three years after its founding, he raised money from private investors in high-tech, including Ilan Shiloah and Moshe Chagg. Today Giktim is a media group that operates a technological news site in Hebrew and English. In addition, the Group operates a high-tech job search database and information about Israeli companies, and enables a match between entrepreneurs and execs. The site will continue to be an independent media of the Israeli high-tech industry and venture capital, managed by Moran Leshem Bar, CEO and CEO.
In March, the group announced a new partnership with Sigma Labs, which was recently operated by the Antra Capital Fund. The Excelator is intended for start-ups that have not yet begun with sales, and is intended to assist those entrepreneurs in their early stages of penetrating new markets. The tenth round of the Axelerator will open under the Sarona Partners group, and will expand from one location to two locations: in Tel Aviv, as a continuation of the existing program, and in Haifa, both in the Sharona Space Group owned by the group. This is in addition to the Excelx 365x, which the company has been operating for about a year, in partnership with Microsoft, Tech Data and ProDevor, which was also founded by Boaz. This program is designed to help start-ups who have begun selling their products to business growth.Another collaboration announced last April is that of Sharona Ventures, a micro-venture capital fund (usually limited to $ 50 million) owned by the group, along with the Peoplebiz investment platform. The cooperation will enable the public to invest in small amounts in the fund’s portfolio companies – through the platform. Sources inform “Globes” that the group intends to raise a number of additional investment funds and to expand its operations abroad. Sources inform “Globes” that Sharona Ventures is currently raising its second fund, the size of which is unknown, and has already made a number of investments.
Among the companies in which the company invested is Verbit, which develops automatic transcription technology; Donde, which develops a visual search for e-commerce sites; Kipras, which develops technology for monitoring children’s messages by their parents; MATRALS ZON, a research platform for scientific data; Plan Your Trip, which develops an application for tour management including; And Itracte Bot, which develops a business chat platform.Boziz, the CEO and founder of Sharona Partners, is a serial investor and investor who has invested in more than 100 companies, and has founded Frodware Group, an information technology (IT) company for businesses, which is managed by Yossi Haimov, 365 in Israel, and performs the localization of the platform, which was established in 1989 and is traded on the Paris Stock Exchange at a market value of € 60 million, and the local branch of ProDur, ProDoor Israel, was established in 2008 and employs slightly more than 150 employees.Alex Boziz, 26, a son of Phillip, is one of the partners in the Sharona Partners group, and has managed to establish and serve as CEO of no less than four technology projects: Lifeslice, SuperKontent, CryptoFighters and Deel. – The investment fund was invested by Sharon Bar-Or, the entrepreneur and investor Daniel Abitbul, businessman Rafael Benadmon, and CTO Gilad Novick. Bar-Or also serves as Marketing and Sales Manager at ProDawer Israel.
Since the group has only a few years, and most of its activity is based on partnerships that began in recent months, it is still too early to know whether Sharona Partners is succeeding in achieving its goal of becoming a platform for Israeli companies to grow into global giants. However, after its massive growth through partnerships and acquisitions, it can be said that Sharona Partners has become one of the broadest and most diverse organizations in the Israeli innovation landscape.Meanwhile Sharona Ventures is still relatively anonymous, and its presence in the market is not obvious. The company does not disclose the size of its fund and the size of its investments, but two investors in Israeli venture capital funds – who participated in the continuing rounds of Sharona Ventures portfolio companies – told “Globes” that they do not know the Sharona Group and that the fund is a passive small investor In companies.ndeed, a “Globes” survey shows that most of Sharona Ventures’ portfolio companies are young start-ups that raised amounts ranging from hundreds of thousands of dollars to just over $ 1 million each. These sums indicate the size of the fund’s investments. In addition, there are several projects in the portfolio that raised a round of funds from the Sharona Ventures Fund, and since then each has raised tens of millions of dollars more from prominent funds in the industry.
The hidden opportunities in the “disruptive”The traditional industry is looking for innovative solutions in high-tech that are changing the industryIn March this year we were informed that the world’s largest fast food chain McDonald’s acquired the Israeli start-up Dynamic Child, which developed a platform that helps automatically match interfaces to end customers. McDonald’s will use Dynamic Child technology to create a personalized experience for its customers in various physical interfaces, such as digital menus and various publications. With this information, the company will be able to immediately offer additional offers based on current customer selections. The acquisition will enable McDonald’s to be one of the first companies to integrate a decision-making system at its physical point of sale, not just online.This acquisition of McDonald’s coincides with the most significant issues of the global retail industry, which is the future selling point. The physical point of sale continues to be a significant axis in meeting customers, creating experience and loyalty and maximizing sales opportunities despite the growth trend of sales in the online arena.
The physical point of sale provides a generic experience with virtually no information around the customer, while the online arena enables personalization of the end user’s shopping experience in view of the large amount of information gathered on the network. This asymmetry has resulted in many companies trying to incorporate in the physical points of sale technological measures that will enable customer identification, best suitability to their needs and improved shopping experiences.This acquisition is an example of the growing trend of a connection between traditional industries and high-tech companies, which we have witnessed in recent years.The connection between traditional industries and technology companies stems from the rise in the rate of renewal required in various industries, from a change in consumer preference, and sometimes from the need to change business models. The rates of change and technological developments sometimes constitute a real limitation for companies that do not have the internal capacity to produce innovation at the required pace. In most cases, the internal limitations stem from the fact that the companies do not have research and development resources, whose establishment involves high costs and significant time investment.
These limitations, along with the need to adopt innovation and leading technologies, have led many companies to resort to “disruptive” deals aimed at finding technological solutions, thereby innovating and adapting the way products and services are developed, sold and consumed. Such transactions are characterized by strategic acquisitions, which allow for relatively rapid and flexible changes in the buyer’s core business.The global market for disruptive transactions is on the rise, with 2018 deals worth $ 217 billion, up 28% from the previous year, with digital and analytics transactions having the most significant volume in recent years.Israel’s perception of the world as a start-up nation and the high concentration of Israeli start-ups led to an increase in the demand for technological assets in light of the fact that purchasers or consumers of technology are not only technology players as in the past. In the last five years alone, significant transactions have been recorded in the Israeli market, such as Waze, Mobilay, Argos and others.This trend, which is expected to continue, is an incentive for the Israeli M & A market, which has become a significant player on the world stage. We expect a continued increase in such transactions, with 2019 expected to increase further in the areas of cyber, Pintek and health. Avway buys the drug company Allergen for $ 63 billion, a 45% premium on the market price
According to a report by The Wall Street Journal, Avway will buy Allergen for more than $ 60 billion. This is a price reflecting a value of $ 188 per share – a 45% premium on the market price
A huge merger in Parma? AbbVie is close to buying the drug company Allergen for about $ 60 billion, according to the Wall Street Journal.According to the report, Avway will pay $ 188 per share of an allergen, a 45% premium on the market price. Allergen’s shareholders will receive $ 120.3 per share and another 0.866 from Avway.Avway’s share plummets 10% on Wall Street in the wake of the report. On the other hand, the share of allergen is about 30%.The report in the Wall Street Journal provides a backwind for the pharmaceutical sector, which today is presenting a merger with a huge premium on the market price. Endo’s share jumps by 5% in Terum, and in the domestic market, too, the report was optimistic when Perrigo rose by 1% and Teva shares rose(2,782 + 0.43%)Recorded a sharp move, from a 1.5% drop to an increase of 3%. It is worth mentioning that the less attractive division of Allergen, Actebis Genrex, acquired Israeli Teva, which took a huge debt and paid $ 45 billion in favor of the matter, a purchase that plunged Israeli society into the depths of debt and currently stands at around $ 27 billion.
Aboy, founded as a spin-off by Abbott in 2013, expects the acquisition to contribute 10 percent to adjusted profit in the first year. The company also expects the acquisition to contribute to the reduction of debt to the range of $ 18-15 billion before the end of 2021.Allergen, based in Dublin, Ireland, will also contribute to the dominance of the Botox market, as well as the $ 8 billion or more beauty industry, as well as some popular eye treatments, when Abavi is preparing to end patent protection for her world’s best-selling drug, Humira. The product portfolios of the two companies have a certain overlap in treatments for the brain, women’s health, stomach and other diseases, which is expected to drag the antitrust deal and the sale of parallel activity. However, the combination with allergen will put Avway into a new area of wrinkle smoothing, eye lengthening and double chin removal.Allergen was supposed to be sold to Pfizer about 3.5 years ago for a significant amount of $ 160 billion, but the US authorities torpedoed the deal.Even before the acquisition attempt by Pfizer, Allergen in her previous incarnation was confronted with a hostile takeover by Valeant, The White Knight, “which saved it from the takeover, was the generic company that bought it in 2014 for a $ 70 billion deal, and a few months later the subsidiary sold its generic arm, Octavis, to Israeli Teva for nearly $ 40 billion, In this market in the US in recent years.
Last month, Allergen reported better-than-expected Q1 earnings, boosting its outlook for the full year as the company’s top-line sales rose 2% to $ 3.6 billion. For the full year, Allergen predicts revenue in the range of $ 15.4-15.1 billion, at a profit of $ 16.55 per share. The forecast is 20 cents higher than the previous forecast by Allergen. MTI buys 50% of an Australian company for NIS 2 millionThe acquired company is the distributor in Australia of MTI’s subsidiary, which deals with water control solutions. The Israeli technology company MTI, which is traded on the secondary London Stock Exchange, is making a small purchase in Australia. The company today announced the acquisition of 50% of Parkland Australia for $ 800,000 (about NIS 2 million).Of the sum, approximately $ 600,000 will be paid upon completion of the transaction within 30 days, and the balance will be paid in two installments in July 2020 and July 2021, based on Farkland’s financial results for the years ending June 2020 and June 2021.
The acquired company is the Australian distributor of the MTI subsidiary, which deals with water control solutions, Mottech Water Solution, which will make the acquisition in practice. The seller of the transaction is Parkland Products of New Zealand; The agreement stipulates that both the buyer and the seller in the transaction will be granted options to purchase the shares of the other party subject to certain conditions.